Headquarters: South San Francisco, California, United States, North America
Description: GenEdit was founded to transform the delivery of gene therapies and enable the next generation of non-viral, gene editing-based therapeutics. GenEdit’s proprietary technology, NanoGalaxy™ platform solves current delivery challenges by systematically screening its nanoparticle library and providing safer and efficient delivery to target tissues. The company's tool makes therapeutic gene editing possible and is easier to use, faster and more accurate than previous gene-editing techniques and thus has the potential for a wide range of therapeutic applications, enabling physicians to cure incurable genetic diseases.
TechStackLeads is a B2B go-to-market search engine. We help sales teams find prospect faster with greate accuracy.
Our search engine indexes companies, jobs, blogs, news, and funding events so you can find the right propsects faster. Enter a keyword or phrase below to see results instantly.